Scientists have developed a new vaccine that could fight seven in ten lethal cancers and is thought to be even more effective than the ‘wonder drug’ Herceptin.
|Last Updated: Dec 13, 2011, 03:39 PM IST|Source: Bureau
London: Scientists have developed a new vaccine that could fight seven in ten lethal cancers and is thought to be even more effective than the ‘wonder drug’ Herceptin, for treatment against tumours.
They found that the new drug shrunk breast tumours by 80 per cent, and believe it could also tackle prostate, pancreatic, bowel and ovarian cancers.
The experiments done so far have been on mice, but the researchers hope to pilot the drug on people within two years.
If all goes well, the vaccine – one of the first to combat cancer – could be on the market by 2020.
Rather than attacking cancer cells, like many drugs, the new treatment harnesses the power of the immune system to fight tumours.
The search for cancer vaccines has until now been hampered by fears that healthy tissue would be destroyed with tumours.
To overcome this, researchers from the University of Georgia and the Mayo Clinic in the United States focused on a protein called MUC1 that is made in bigger amounts in cancerous cells than in healthy ones.
Not only is there more of it, but a sugar that it is ‘decorated’ with has a distinctive shape.
The vaccine ‘trains’ the immune system to recognise the rogue sugar and turn its arsenal against the cancer.
“Cancer cells have a special way of thwarting the immune system by putting sugars on the surface of tumour cells so they can travel around the body without being detected,” an English daily quoted researcher Professor Sandra Gendler as saying.
“To enable the immune system to recognise the sugar, it took a special vaccine that had three parts to it. That turned out to be a winning combination,” she explained.
Her co-author Professor Geert-Jan Boons said it reduces tumour size to 80 per cent.
“This vaccine elicits a very strong immune response. It activates all three components of the immune system to reduce tumour size by an average of 80 per cent,” Boons stated.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.